Neoplastic (malignant) related fatigue. Neoplastic (malignant) related fatigue
Conditions
Interventions
Intervention group:Administrating 80 ml "nokhod-ab" three times a day for three weeks.
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age between 18- 70 years old Patients known case of cancer Hemoglobin level is at least 8 g / dl Hematocrit level at least 30% The level of TSH is normal
Exclusion criteria
Exclusion criteria: Patients known case of heart disease with unstable conditions Disabling Pulmonary Disease and History of Asthma Patients known case of severe kidney disease Creatinine level is greater than 2mg / dl Proteinuria The SGOT level is more than 3 times of the normal threshold Bilirubin levels is greater than 2mg / dl Positive history of hypersensitivity to saffron, cinnamon, peas Uncontrolled pain, severe infection, serious illness Positive history of gout or high level of uric acid An individual who uses antidepressants due to depression Simultaneous use of drugs that affect fatigue Unwillingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Score of Fatigue Severity "Visual Analogue Fatigue Scale". Timepoint: Three weeks. Method of measurement: Using Visual Analogue Fatigue Scale questionnaire.;Score of "Fatigue Severity". Timepoint: Three weeks. Method of measurement: Fatigue Severity Scale questionnaire.;Score of "The Cancer Fatigue Scale". Timepoint: Three weeks. Method of measurement: The Cancer Fatigue Scale questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghazaleh Heydarirad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed